Brinzolamide Suspension/ Drops
Product Images NDC 68682-464

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Brinzolamide (NDC 68682-464). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oceanside Pharmaceuticals., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem (Image 01)

Chemical structure of brinzolamide, the active ingredient in BRINZOLAMIDE ophthalmic suspension 10 mg/mL by Oceanside Pharmaceuticals. The diagram illustrates the molecular arrangement typical of the compound.*

FDA Label Image

Carton (Image 02)

Packaging label for Brinzolamide Ophthalmic Suspension USP 1%, 10 mL bottle, by Oceanside Pharmaceuticals. The label includes active ingredient strength, usage instructions for ophthalmic route, storage conditions, and warnings such as not touching the dropper tip to surfaces and ensuring the neckband is intact before use. Distributed by Oceanside Pharmaceuticals, a division of Bausch Health US, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.